Remove tag evidence
article thumbnail

What you need to know about treating skin tags

The Checkup by Singlecare

Skin tags are one of those things you probably don’t think about until you spot one. At first glance, you may fear it’s a symptom of psoriasis , eczema , HPV warts, or skin cancer —but skin tags are common, noncancerous, and essentially harmless. Read on to see what experts say about the following 13 home remedies for skin tags.

FDA 115
article thumbnail

J&J builds case for antidepressant Spravato with head-to-head trial

pharmaphorum

Yesterday, the drugmaker added to the evidence behind Spravato – an intranasal formulation of esketamine – with the release of top-line data from a head-to-head study with a long-acting formulation of the antipsychotic quetiapine, which is also used to treat TRD.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Can gene therapies for haemophilia defend their high price tags?

Pharmaceutical Technology

On November 2, the Institute for Clinical and Economic Review (ICER) released its updated evidence aimed at measuring the clinical effectiveness and cost of the two haemophilia gene therapies. million price tag. The post Can gene therapies for haemophilia defend their high price tags? million ($1.8 million at the time).

FDA 111
article thumbnail

NICE says yes to Novartis’ multiple sclerosis therapy Kesimpta

pharmaphorum

NICE’s final appraisal document for Kesimpta will be followed by technology appraisal guidance (TAG) that will pave the way for NHS prescribing in England and Wales. Nearly nine out of ten patients treated with Kesimpta saw no evidence of disease activity in their second year of treatment with the drug.

Hospitals 111
article thumbnail

Pear claims breakthrough tag for alcohol use disorder DTx

pharmaphorum

reSET-A is still in development and has not yet been approved by the FDA, but could help “bring effective, evidence-based treatments for alcohol use disorder to many more people,” according to the digital health company’s chief medical officer Yuri Maricich. Photo by thom masat on Unsplash.

FDA 59
article thumbnail

Upcoming sickle cell gene therapies cost effective at $2 million, says ICER

Pharmaceutical Technology

Two gene therapies up for approval this year for sickle cell disease could be cost effective in some cases at a $2 million price point, based on a draft evidence report published by the Institute for Clinical and Economic Review (ICER). Still, comparing the two therapies remains difficult, with ICER rating the evidence as insufficient.

FDA 59
article thumbnail

ICER says bluebird bio’s $2.1m gene therapy is cost-effective

pharmaphorum

million price tag. In its report, ICER said there remain uncertainties about beti-cel, including the durability of the treatment and side effects, but concluded that on balance “the evidence suggests that beti-cel provides net health benefits to patients with TDT.”

FDA 64